Shenzhen Ousida Technology Co., Ltd , https://en.osdvape.com
Optimistic about healthy lighting? Pharmaceutical companies have a large shareholding
On October 18, Tiansheng Pharmaceutical made two significant foreign investment announcements. First, the company decided to invest RMB 14.6 million of its own funds into Chongqing Guangyao Optoelectronics Technology Co., Ltd., acquiring a 20% stake in the firm. This move marks Tiansheng's entry into the health lighting sector. Additionally, the company signed a "Project Investment Contract" with the Weinan District Government of Chongqing, planning to establish a local limited company to build a medical consumables production project with an estimated total investment of 360 million yuan.
Chongqing Guangyao Optoelectronics, established in December 2013 with a registered capital of 30 million yuan, specializes in computer and energy-saving lighting solutions. The company has made several groundbreaking discoveries in the fields of health and energy-saving lighting, including advanced laser lighting technology. To date, it has filed over 20 patents related to laser lighting and plans to submit more than 80 additional patents in the same area this year.
The Weinan Medical Consumables Production Project is located in the southern part of the Weinan Industrial Park. The site will be provided by the Weinan District Government in coordination with the Ministry of Land and Resources. The project will focus on manufacturing medical products such as infusion sets, syringes, and other essential medical supplies. The government has pledged full market access for all pharmaceutical products, consumables, and medical equipment produced by Tiansheng, including inclusion in the local medical consortium catalog. Public medical institutions will prioritize procurement of these products under the same conditions, ensuring no barriers to entry.
Tiansheng Pharmaceutical stated that these investments will enrich its industrial chain, expand its business operations, support the implementation of its future industrial strategy, and generate substantial economic benefits for the company.
Notably, on September 26, Tiansheng also signed a "Strategic Cooperation Framework Agreement" with the Ganzhou Municipal Government of Sichuan Province and an "Investment Contract for Tianzhou Pharmaceutical Group’s Zhangzhou Pharmaceutical and Logistics Project" with the Jixian County Government. This collaboration aims to develop pharmaceutical manufacturing, logistics distribution, innovation platforms, and talent exchange through the Zhangzhou National High-tech Zone pharmaceutical industry park. The project is expected to involve a total investment of about 500 million yuan and occupy approximately 65 acres of land. It will include large- and small-volume injection production lines, oral solid preparation lines, pharmaceutical logistics warehouses, and quality inspection centers. Construction is scheduled to take 22 months, with an estimated annual output value of 500 million yuan once operational.